Single Lung Transplant Surgery Recovery, Weeks 5–8: Pulmonary Rehabilitation and Graft Optimization
Weeks 5–8 after single lung transplant surgery make up phase 2 of 4 in a typical 16-week recovery: Pulmonary Rehabilitation and Graft Optimization. Your own surgeon's instructions always come first.
Goals for weeks 5–8
- Formal outpatient pulmonary rehabilitation should be well underway during Phase 2 and should be pursued aggressively. Lung transplant rehabilitation differs from standard pulmonary rehabilitation in important ways. The transplanted lung is denervated, meaning that respiratory drive and airway responses are altered. However, the lung parenchyma itself functions normally — gas exchange, perfusion, and alveolar mechanics are those of a healthy donor organ. The goal of rehabilitation is to rebuild the skeletal muscle deconditioning, cardiovascular fitness, and functional capacity that deteriorated during months or years of end-stage lung disease.
- Exercise prescription for lung transplant patients uses rate of perceived exertion (RPE) rather than relying solely on heart rate or oxygen saturation targets, because the interaction between the denervated transplanted lung and the innervated cardiovascular system creates variable physiologic responses. Walking should progress from the short distances of Phase 1 to sustained walking of 20 to 40 minutes. Resistance training for both upper and lower extremities is introduced, with particular attention to the muscles of the upper back and shoulder that may be weakened by the posterolateral thoracotomy incision and the deconditioning of pre-transplant illness. Balance and flexibility exercises complement the strength and endurance components.
- Patients who commit to aggressive rehabilitation after single lung transplant can achieve meaningful functional recovery, though the ceiling is lower than bilateral transplant because the native lung (with its underlying disease) remains and limits overall pulmonary reserve. For patients transplanted for emphysema, the retained hyperinflated native lung may compress the graft to some degree, limiting the FEV1 that can be achieved. For patients transplanted for fibrosis, the retained stiff native lung contributes restrictive physiology. Understanding this limitation helps set realistic expectations while still encouraging maximum effort in rehabilitation.
- Daily FEV1 and FVC measurements continue as a non-negotiable part of post-transplant life. By Phase 2, you should have established a baseline personal best FEV1 against which all future measurements are compared. The critical alarm threshold remains a decline of more than 10 percent from this baseline, but even smaller declines (5 to 10 percent) sustained over several days warrant notification to your transplant team. Spirometry trends over time are more informative than single measurements, which can vary with technique, time of day, and transient airway inflammation. Performing measurements at the same time each day under consistent conditions improves reliability.
- Corticosteroid-induced osteoporosis is one of the most consequential long-term side effects of transplant immunosuppression. Bone loss begins within the first weeks of corticosteroid therapy and is most rapid in the first 6 to 12 months. The thoracotomy places mechanical demands on the rib cage that make fracture prevention particularly relevant. Calcium and vitamin D supplementation should be started if not already in place, and many transplant programs initiate bisphosphonate therapy (such as alendronate or zoledronic acid) within the first month of transplant based on bone density assessment. Weight-bearing exercise during pulmonary rehabilitation provides additional bone protection.
- Immunosuppressed transplant recipients have a dramatically increased risk of skin cancer, particularly squamous cell carcinoma, which is not only more common but also more aggressive in immunosuppressed patients. Sun protection must begin during this phase if not already established and must continue lifelong. This means broad-spectrum sunscreen (SPF 30 or higher) applied to all exposed skin when outdoors, protective clothing including wide-brimmed hats, and avoidance of deliberate sun exposure and tanning. Annual full-body skin examinations by a dermatologist should be established as part of the long-term transplant surveillance calendar.
What to avoid in weeks 5–8
- Lifting restrictions easing (progress to 10 kg by week 6-8 if wound healing permits)
- Continue all immunosuppression exactly as prescribed
- Continue infection precautions (easing slightly but still significant)
- No NSAIDs (lifelong)
- No grapefruit (lifelong)
- Sun protection (lifelong)
- No new medications or supplements without transplant team approval
- No smoking or secondhand smoke (absolute, lifelong)
← Weeks 1–4: ICU, Inpatient, and Early Post-Discharge Recovery · Weeks 9–12: Expanding Independence and Functional Recovery →
See the whole recovery timeline →
Follow weeks 5–8 in Surgily
Surgily shows each day's exercises for this phase, lets you log how you feel in 30 seconds and share it with your care team, and tells you clearly when to get help.
Get my recovery plan →